BioScience Well Positioned to Achieve >$12B by 2010
2001
2010
$2.8 Billion
>$12 Billion
CAGR = 17%+
BioScience will be a Global BioScience Leader with Innovative BioPharmaceuticals, Vaccines, BioSurgery, & Transfusion Therapies Products and Services
Previous slide
Back to first slide
View graphic version